![Chia Ching Chen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Chia Ching Chen
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 11 | |
Subsidiary | Pharmaceuticals: Major | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Chia Ching Chen
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
StemCyte, Inc.
![]() StemCyte, Inc. BiotechnologyHealth Technology StemCyte, Inc. operates as a biotechnology company that collects, banks and distributes cord blood stem cell transfusion units. It focuses on stem cell transplantation, therapy, applications, diagnostics, and genomic research. The firm uses insulated containers to keep your baby's cord blood cool throughout transport. The company was founded by Denis Rodgerson and Robert Chow in 1997 and is headquartered in Covina, CA. | Biotechnology | Chairman | |
Epitomics, Inc.
![]() Epitomics, Inc. Pharmaceuticals: MajorHealth Technology Epitomics, Inc. an emerging biotechnology company, is dedicated to developing their breakthrough monoclonal antibody technology (RabMAb®) for research, diagnostics and therapeutics. The Company has utilized a unique and proprietary RabMAb technology invented by scientists at Loyola University of Chicago and the University of California at San Francisco. This enabling platform produces high quality antibodies that have the potetial to be used in the broad areas of research, diagnostics and therapeutics. Compared to currently available monoclonal antibody technology, such as mouse hybridomas, the company's proprietary technology can generate RabMAbs more efficiently and with superior binding affinity and bioactivity in a wide variety of biological assays. The high throughput and robust nature of the technology allows for the simultaneous discovery of disease targets and potential therapeutic antibodies in the same experiments, significantly shortening the drug discovery and development cycle. The company aims to become the largest provider of monoclonal antibody technology through developing and commercializing their RabMAb technology and products in research, diagnostics, and therapeutics. The firm is headquartered in Burlingame, California and operates a wholly owned subsidiary in Hangzhou, the People's Republic of China. | Pharmaceuticals: Major | Director/Board Member | |
SCINOPHARM TAIWAN, LTD. | Biotechnology | Chief Operating Officer | |
University of Washington
![]() University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Masters Business Admin | |
KGI Securities Co., Ltd.
![]() KGI Securities Co., Ltd. Investment Banks/BrokersFinance KGI Securities Co., Ltd. provides securities broking, underwriting, and proprietary trading services. It also offers investment banking consultancy, warrants issuance, bonds conversion, fixed income trading, and wealth management services. Its products include derivatives, bond and equity options, mutual funds, and structured products. The company was founded on September 14, 1988 and is headquartered in Taipei, Taiwan. | Investment Banks/Brokers | Corporate Officer/Principal | |
Sycamore Management Corp.
![]() Sycamore Management Corp. Investment ManagersFinance Sycamore Management Corp. (dba Sycamore Ventures) is an independent asset management firm headquartered in Princeton, New Jersey. The firm was founded in 1995 by Joseph Cho and Peter Gerry. Sycamore Ventures manages investment portfolios for individual and institutional clients. | Investment Managers | Portfolio Manager-Equities | |
China Investment & Development Co. Ltd.
![]() China Investment & Development Co. Ltd. Investment ManagersFinance China Investment & Development Co Ltd invests in Taiwan-based companies operating in the field of financial services. It provides financing for early and later stage capital requirements. | Investment Managers | President | |
Indiana University | College/University | Graduate Degree | |
Sycamore Ventures Pte Ltd.
![]() Sycamore Ventures Pte Ltd. Investment ManagersFinance Sycamore Ventures Pte Ltd. (Sycamore Ventures) is a private equity and venture capital subsidiary of Sycamore Management Corp., founded in 1995 by Mr. Kilin To, Mr. Peter Gerry, and the late Mr. John Whitman. The firm is headquartered in Princeton, New Jersey. | Investment Managers | Private Equity Investor | |
New York University | College/University | Doctorate Degree | |
The Ohio State University
![]() The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | College/University | Doctorate Degree | |
University of Wisconsin | College/University | Doctorate Degree | |
University of Georgia | College/University | Doctorate Degree | |
University of Iowa | College/University | Graduate Degree | |
University of Kentucky | College/University | Graduate Degree | |
U-Systems, Inc.
![]() U-Systems, Inc. Medical SpecialtiesHealth Technology U-Systems, Inc. designs, develops, manufactures and markets ultrasound systems. The company was founded in 1997 and is headquartered in Schenectady, NY. | Medical Specialties | Director/Board Member | |
National Taiwan University | College/University | Undergraduate Degree Undergraduate Degree | |
National Tsing-Hua University | College/University | Graduate Degree | |
CIDC Consultants, Inc.
![]() CIDC Consultants, Inc. Investment ManagersFinance CIDC Consultants, Inc. (CIDC Consultants) is an independent, Taiwan-based venture capital firm which was established in 1988 to offer management consulting, serve as an intermediary for domestic and foreign investment, facilitate investment-related technology cooperation, provide business intelligence and deliver inquiry services for venture capital firms. Located in Taipei, the firm manages funds backed by Taiwanese companies in a range of industries and works with European and American partners to make joint investments. CIDC has a cooperative relationship with Doughty Hanson & Co. and their affiliate, Global Financial Services, helps their investee companies to establish sound financial systems. ? | Investment Managers | President | |
KGI Capital Asia Ltd.
![]() KGI Capital Asia Ltd. Investment Banks/BrokersFinance Part of China Development Financial Holding Corp., KGI Capital Asia Ltd. is a brokerage firm. The company is based in Hong Kong, Hong Kong. The CEO of the Chinese company is Pun Yuen Lam. | Investment Banks/Brokers | Director/Board Member | |
Development Center for Biotechnology
![]() Development Center for Biotechnology Medical/Nursing ServicesHealth Services The Development Center for Biotechnology of Taiwan is a nonprofit organization co-sponsored by government grants and private donations. It focuses on biotechnology and pharmaceutical industry. The company was founded in 1984 and is headquartered in Taipei, Taiwan. | Medical/Nursing Services | Corporate Officer/Principal | |
MAXIGEN BIOTECH INC. | Biotechnology | President | |
National Defense Medical Center | College/University | Undergraduate Degree | |
ADVANCED LITHIUM ELECTROCHEMISTRY (CAYMAN) CO., LTD. | Chemicals: Specialty | Chief Executive Officer | |
COLAND HOLDINGS LIMITED | Pharmaceuticals: Major | Director/Board Member | |
TWi Pharmaceuticals Holding, Inc.
![]() TWi Pharmaceuticals Holding, Inc. Pharmaceuticals: MajorHealth Technology TWi Pharmaceuticals Holding, Inc. provides pharmaceutical services. | Pharmaceuticals: Major | Director/Board Member | |
Eldridge Capital Group Ltd. | Director/Board Member | ||
ACTS Biotech, Inc. | Chairman | ||
DV BIOMED CO., LTD. | Biotechnology | Director/Board Member | |
Allgenesis Biotherapeutics, Inc.
![]() Allgenesis Biotherapeutics, Inc. BiotechnologyHealth Technology Allgenesis Biotherapeutics, Inc. is a Taiwanese clinical-stage biopharmaceutical company focused on researching and developing novel medicines for the treatment of eye diseases. The private company is based in Taipei, Taiwan. The company's current pipeline includes potential blockbuster drugs such as ag-73305 for the treatment of DME, NAMD, and other retinal diseases, as well as ag-80308 for dry eye disease. The company was founded by Chih Lung Shen and Chih Ming Chen. Madhu Cherukury has been the CEO of the company since 2014. | Biotechnology | Founder | |
Delightful Cheers Ltd. | Director/Board Member |
Statistik
International
Vereinigte Staaten | 18 |
Taiwan | 16 |
Cayman Islands | 3 |
Hong Kong | 2 |
Sektoral
Health Technology | 13 |
Consumer Services | 12 |
Finance | 7 |
Commercial Services | 2 |
Health Services | 2 |
Operativ
Director/Board Member | 17 |
President | 8 |
Chairman | 7 |
Corporate Officer/Principal | 6 |
Independent Dir/Board Member | 5 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Li Yan Chang | 11 |
Jonas Wang | 10 |
Chih Ming Chen | 9 |
Yi Chun Wu | 6 |
Yueh Yueh | 3 |
Nien Hua Liu | 2 |
Sen Hsiung Chang | 2 |
Chu Chun Weng | 2 |
Kuang Wei Lu | 2 |
Lien I Ho | 1 |
Pei Lan Chu | 1 |
Rick Pallokat | 1 |
Emily Lin | 1 |
Pei Chih Chen | 1 |
- Börse
- Insiders
- Chia Ching Chen
- Unternehmensverbindungen